Found: 11
Select item for more details and to access through your institution.
Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 1, p. 79, doi. 10.1177/08971900211021249
- By:
- Publication type:
- Article
Improved Organizational Outcomes Associated With Incorporation of Early Clinical Experiences for Second-Year Student Pharmacists at an Academic Medical Center.
- Published in:
- Journal of Pharmacy Practice, 2017, v. 30, n. 1, p. 99, doi. 10.1177/0897190015585765
- By:
- Publication type:
- Article
Minimizing cost associated with management of heparin‐induced thrombocytopenia: A cost analysis of various laboratory testing models.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 6, p. 1599, doi. 10.1111/ijlh.13658
- By:
- Publication type:
- Article
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 7, p. 1695, doi. 10.1177/1078155220934862
- By:
- Publication type:
- Article
Impact of a multidisciplinary workflow on safety and management of patients with heparin-induced thrombocytopenia.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 1, p. 49, doi. 10.1093/ajhp/zxaa342
- By:
- Publication type:
- Article
Importance of pharmacokinetic studies in the management of acquired factor X deficiency.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 1, p. 60, doi. 10.1111/ejh.12548
- By:
- Publication type:
- Article
Incidence and time course of neutropenia in patients treated with rituximab‐based therapy for non‐malignant immune‐mediated hematologic diseases.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. E117, doi. 10.1002/ajh.25751
- By:
- Publication type:
- Article
Adherence to infectious disease screening and immunization guidelines when treating non‐malignant immune‐mediated hematologic disorders.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E72, doi. 10.1002/ajh.25710
- By:
- Publication type:
- Article
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 974, doi. 10.1111/hae.14393
- By:
- Publication type:
- Article
Emicizumab reduces re‐hospitalization for bleeding in acquired haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e585, doi. 10.1111/hae.14335
- By:
- Publication type:
- Article
Recombinant porcine factor VIII use in bleed treatment in non‐severe haemophilia A inhibitor patients: Dosing strategies and efficacy.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. e147, doi. 10.1111/hae.14111
- By:
- Publication type:
- Article